ReviewJournal of translational autoimmunity2022

Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases.

Carlos A Cañas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.